major acquisition
additional shares
best performing stock
beat wall street
beat earning
beat street
breathing room
bullish sentiment
decrease short interest
eye catching
fall short interest
FDA Approval
drop bucket
earning beat
free cash flow
grow revenue
granted marketing authorization
good pipeline
growth opportunities
high confidence
great pipeline
increase earnings
increase dividend 
increase demand
increase stake
increase target
interesting play
low risk
less risk
leading technology
new stake
raised its stake
phase three
positive earning
price surging
raise guidance
raise target
remains strong
sales increased
strong pipeline
significant growth
strong outlook
topped the analyst
week high
